Therefore, blocking of PD-1/PD-L1 pathway in the treatment of cervical cancer may be helpful in restoring T cell proliferation ability in tumor microenvironment, generating more effector cell factors, and enhancing immune effect against cervical cancer. This evidence concerns the gene CD274 and cervical carcinoma.